Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Humoral Immune Deficiency in Patients With Frequent Exacerbations of COPD, and the Effect of Immunoglobulin Replacement on Future Exacerbations

NCT05764993 is registered in ClinicalTrials.gov with Rochester General Hospital as lead sponsor.

NCT NCT05764993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05764993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Humoral Immune Deficiency in Patients With Frequent Exacerbations of COPD, and the Effect of Immunoglobulin Replacement on Future Exacerbations
Lead sponsor
Rochester General Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
June 1, 2023
Completion date
December 30, 2025
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation acute